Comparison

DMPK Antibody (C-term) Blocking Peptide

Item no. ABC-BP7034b
Manufacturer Abcepta
Amount 500 ug
Category
Type Peptides
Format Lyophilized
Specific against other
Citations Gennarelli, M., et al., Biochem. Biophys. Res. Commun. 216(2):489-494 (1995).Sasagawa, N., et al., FEBS Lett. 351(1):22-26 (1994).Mahadevan, M.S., et al., Hum. Mol. Genet. 2(3):299-304 (1993).Shaw, D.J., et al., Genomics 18(3):673-679 (1993).Fu, Y.-H., et al., Science 260(5105):235-238 (1993).
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Myotonin-protein kinase,MT-PK,DM-kinase,DMK,DM1 protein kinase,DMPK,Myotonic dystrophy protein kinase,DMPK,DM1PK,MDPK
Similar products DMPK, DM1PK, MDPK, Myotonin-protein kinase, DM-kinase, DM1 protein kinase, Myotonic dystrophy protein kinase, DMK, MT-PK
Available
Manufacturer - Category
Peptides; Blocking Peptides
Manufacturer - Targets
The synthetic peptide sequence used to generate the antibody AP7034b was selected from the C-term region of human DMPK. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Bio Background
DMPK, a member of the Ser/Thr protein kinase family, may play a role in intracellular communication. Most DMPK isoforms are expressed in many tissues including heart, skeletal muscle, liver and brain, except for isoform 2 which is only found in the heart and skeletal muscle, and isoform 14 which is only found in the brain, with high levels in the striatum, cerebellar cortex and pons. The poly-Gln region upstream/downstream of the gene is highly polymorphic (5 to 27 repeats) in the normal population and is expanded up to 50-3000 or more repeats in DM patients. The repeat length usually increases in successive generations, but not always. Defects in DMPK are the cause of myotonic dystrophy (DM), also known as Steinert disease. DM is an autosomal dominant neurodegenerative disorder characterized by myotonia, muscle wasting in the distal extremities, cataract, hypogonadism, defective endocrine functions, male baldness, and cardiac arrhythmias. DM patients show decreased levels of kinase expression inversely related to repeat length. The minimum estimated incidence is 1 in 8000 live births.
Gene Name
DMPK
Subtitle
Synthetic peptide
Formulation
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close